The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1971, 107: 742-750.
Copyright © 1971 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruddy, S.
Right arrow Articles by Austen, K. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ruddy, S.
Right arrow Articles by Austen, K. F.

C3b Inactivator of Man

II. Fragments Produced by C3b Inactivator Cleavage of Cell-Bound or Fluid Phase C3b1

Shaun Ruddy2 and K. Frank Austen

From the Department of Medicine, Harvard Medical School at the Robert B. Brigham Hospital, Boston, Massachusetts

Abstract

C3b inactivator (C3bINA), a normal serum protein that destroys the ability of cells bearing C3b to participate in immune adherence, to undergo enhanced phagocytosis by polymorphonuclear leukocytes and to react with subsequent components of the complement system, was studied. C3bINA treatment of EAC14oxy23 cells prepared with purified and radiolabeled C3 released two bands of radioactive protein that were distinguishable from C3b on polyacrylamide disc gel electrophoresis. Similar products were demonstrable following the interaction of fluid phase C3b with C3bINA. The more anodal band appeared to be identical to C3c or beta1A on the basis of electrophoretic mobility, behavior on gel filtration and antigenic content. The portion of C3 that remained on the cell following C3bINA treatment resembled C3d or {alpha}2D in its antigenicity. The action of C3bINA in vivo to produce cells coated only with C3d could account for absence of immune adherence reactivity and resistance to lysis of erythrocytes circulating in patients with certain forms of hemolytic anemia.

Footnotes

1 This work was supported by Grant AI-07722 from the National Institutes of Health, a grant from the John A. Hartford Foundation, Inc., and a grant from the Massachusetts Chapter, Arthritis and Rheumatism Foundation.

2 Investigator, Howard Hughes Medical Institute.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
K. M. Hovis, J. C. Freedman, H. Zhang, J. L. Forbes, and R. T. Marconi
Identification of an Antiparallel Coiled-Coil/Loop Domain Required for Ligand Binding by the Borrelia hermsii FhbA Protein: Additional Evidence for the Role of FhbA in the Host-Pathogen Interaction
Infect. Immun., May 1, 2008; 76(5): 2113 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. V. McDowell, J. Frederick, L. Stamm, and R. T. Marconi
Identification of the Gene Encoding the FhbB Protein of Treponema denticola, a Highly Unique Factor H-Like Protein 1 Binding Protein
Infect. Immun., February 1, 2007; 75(2): 1050 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. V. McDowell, K. M. Hovis, H. Zhang, E. Tran, J. Lankford, and R. T. Marconi
Evidence that the BBA68 Protein (BbCRASP-1) of the Lyme Disease Spirochetes Does Not Contribute to Factor H-Mediated Immune Evasion in Humans and Other Animals.
Infect. Immun., May 1, 2006; 74(5): 3030 - 3034.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. M. Hovis, J. P. Jones, T. Sadlon, G. Raval, D. L. Gordon, and R. T. Marconi
Molecular Analyses of the Interaction of Borrelia hermsii FhbA with the Complement Regulatory Proteins Factor H and Factor H-Like Protein 1
Infect. Immun., April 1, 2006; 74(4): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. V. McDowell, J. Lankford, L. Stamm, T. Sadlon, D. L. Gordon, and R. T. Marconi
Demonstration of Factor H-Like Protein 1 Binding to Treponema denticola, a Pathogen Associated with Periodontal Disease in Humans
Infect. Immun., November 1, 2005; 73(11): 7126 - 7132.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. V. McDowell, J. Wolfgang, L. Senty, C. M. Sundy, M. J. Noto, and R. T. Marconi
Demonstration of the Involvement of Outer Surface Protein E Coiled Coil Structural Domains and Higher Order Structural Elements in the Binding of Infection-Induced Antibody and the Complement-Regulatory Protein, Factor H
J. Immunol., December 15, 2004; 173(12): 7471 - 7480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Blom, B. O. Villoutreix, and B. Dahlback
Mutations in {alpha}-Chain of C4BP That Selectively Affect Its Factor I Cofactor Function
J. Biol. Chem., October 31, 2003; 278(44): 43437 - 43442.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K Whaley and S Ruddy
Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator
Science, September 10, 1976; 193(4257): 1011 - 1013.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1971 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1971 by The American Association of Immunologists, Inc. All rights reserved.